Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lachesis muta snake venom metalloproteinases (SVMPs) are a diverse group of zinc-dependent enzymes that constitute a major portion of the venom of the South American Bushmaster (Lachesis muta) [1, 3]. These enzymes are classified into P-I, P-II, and P-III groups based on their domain architecture, with P-III types typically being the most potent inducers of hemorrhage [2]. Biologically, SVMPs function by degrading basement membrane components of capillary blood vessels, such as type IV collagen, laminin, and fibronectin, leading to microvascular disruption and profuse bleeding [4]. They also interfere with the hemostatic system by activating or degrading clotting factors and inhibiting platelet aggregation [6]. In the context of disease, SVMPs are the primary drivers of local tissue necrosis, edema, and systemic coagulopathy observed in bushmaster envenomation [3, 5]. Therapeutic strategies focus on neutralizing these enzymes using specific antivenoms or small-molecule inhibitors like metal chelators (e.g., Unithiol) and peptidomimetic hydroxamates (e.g., Batimastat), which target the catalytic zinc site [5, 7]. These interventions are critical for preventing the rapid, often irreversible, tissue destruction and systemic hemorrhage that characterize Lachesis envenomation [8].
Inhibition of enzymatic activity through chelation of the essential zinc ion (Zn2+) required for proteolytic activity or antibody-mediated neutralization of the enzyme functional domains [5, 6].
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lachesis muta snake venom metalloproteinase (LmSVMP) (LmSVMP).